‘It’ll be a challenge’: BIO chief Crowley addresses seismic FDA overhaul

WASHINGTON — The size and scope of the FDA that began Tuesday won’t be the same as the day nears a brutal conclusion for agency staffers that were laid off or forced to resign. Sitting in ...